Polatuzumab Vedotin With R-GDP in Relapsed/Refractory Diffuse Large B-cell Lymphoma
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
University College, London
Hoffmann-La Roche
Incyte Corporation
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
Gilead Sciences
City of Hope Medical Center
Canadian Cancer Trials Group
Molecular Templates, Inc.
CTI BioPharma
Pfizer
Eli Lilly and Company
M.D. Anderson Cancer Center
Celgene
Northwestern University
Pfizer
Fred Hutchinson Cancer Center
SWOG Cancer Research Network